Microbes have made a phenomenal contribution to the health and well-being of people throughout the world.1 Nowadays, drug discovery from microbial natural products has become more and more difficult. However, it is not the end of an era but an endless frontier.2 To explore more bioactive compounds, a strain of Streptomyces avermitilis NEAU1069 that produced milbemycins was isolated from a soil sample.3 Later, two novel macrolide compounds with a cyclohexyl group at the position of C-25, such as doramectin and avermectin B1a, were obtained from the fermentation broth, using bioactivity guided fractionation method, on adding cyclohexanecarboxylic acid to the fermentation medium.4 The co-existence of milbemycins and avermectin implies that S. avermitilis NEAU1069 is an interesting strain and merits further study. Therefore, large amounts of fermentation broth (30 l) were collected and the detailed constituents were investigated; two other new compounds 1 and 2 (Figure 1), similar to doramectin, were subsequently obtained. Here we describe the fermentation, isolation and structure elucidation of these two new doramectin analogs 1 and 2.

Figure 1
figure 1

Structures (a) and key 1H-1H COSY, HMBC correlations (b, c) of compounds 1 and 2.

Compound 1 was obtained as a white amorphous powder. Its molecular formula was established to be C44H68O11 as deduced from the high-resolution electron spray ionization (HRESI)-MS and 13C NMR data (Table 1). The IR spectrum of 1 showed absorption bands assignable to the hydroxyl group (3447 cm−1) and an ester carbonyl (1705 cm−1). The 1H NMR (400 MHz, CDCl3) data (Table 1) of 1 displayed three doublet aliphatic methyls at δ 0.90, 1.18, 1.28; three olefinic methyl signals at δ 1.55, 1.72, 1.82; two methoxy signals at δ 3.37, 3.51; one trans-double bond at δ 5.59 (dd, J=10.0, 14.8 Hz) and δ 6.00 (dd, J=10.8, 14.8 Hz). Its 13C NMR spectrum revealed 44 carbon resonances, including an ester carbonyl carbon at δ 174.1 (s), a ketal carbon at δ 99.6 (s), 5 sp2 methines, 3 sp2 quaternary carbons, 3 secondary methyls, 3 vinylic methyls, 11 methylenes, 14 aliphatic methines (10 oxygenated), 1 oxygenated quaternary carbon and 2 methoxy groups. The above data accounted for 65 protons, indicating the presence of three free hydroxyl groups in 1. Comparison of the 1H NMR data of 1 with those of selamectin5 and doramectin6 suggested that compound 1 was structurally related to doramectin and selamectin (Figure 1). The differences between 1 and selamectin were in C-5, C-6, C-8 and C-23. The 1H-1H COSY and HMBC spectra (Figure 1b) fulfilled the assignment of the structure of 1. The observed HMBC correlations from δH 1.82 (4-Me) and one of methoxy proton signal to C-5 (δ 77.2) demonstrated that the hydroxyimino group in selamectin was replaced by a methoxy group in 1. The correlation of H-5 and H2-6 in the 1H-1H COSY spectrum showed the C-6 was a methylene. The HMBC correlations between δH 1.72 (8-Me) and δC 76.2 (s, C-7), δC 136.8 (s, C-8), δC 124.6 (d, C-9) revealed a methyl group was substituted at C-8. A hydroxyl group attached to C-23 was also supported by the HMBC correlation from the δH 0.90 (24-Me) to δC 70.0 (d, C-23). As a consequence, the gross structure of 1 was established.

Table 1 1H and 13C NMR data of compounds 1 and 2

The relative stereochemistry of 1 was assigned on the basis of the concurrence with those of doramectin and 25-cyclohexyl-avermectin B2.6

To confirm the assignment of the sugar moiety of 1, acid hydrolysis of 1 was performed, and afforded an aglycone and a sugar. The sugar component was identified by TLC co-chromatography with the sugar obtained by acid hydrolysis of selamectin. The identical RF values of the two resulting sugars indicated that compound 1 and selamectin possessed the same sugar moiety.

Compound 2 was obtained as a white amorphous powder. Its molecular formula was established to be C43H62O10 on the basis of HRESI-MS at m/z 761.4225 [M+Na]+ (calculated as 761.4235 for C43H62NaO10). The 1H NMR spectrum of 2 displayed a methoxy group at δ 3.52 and two downfield proton signals at δ 6.62, 7.40. Its 13C NMR spectrum showed 43 carbon resonances, including 7 methyls (1 oxygenated), 10 methylenes, 12 aliphatic methines (9 oxygenated), 12 sp2 carbons, a ketal carbon and an ester carbonyl group. This suggested that 2 was also a doramectin derivative. Comparison of the 1H and 13C NMR data of 2 with those of 1, the differences between 2 and 1 were in C-2 to C-7 moiety in addition to the absence of a methoxy in 2. Further, comparing the 1H and 13C NMR data of C-2 to C-7 moiety of 2 with those of the same structural units in milbemycin β3,7, 8, 9 β4,10, 11 β13, β14,12 suggested that the C-2 to C-7 moiety in 2 was an aromatic ring as that of milbemycin β3, β13, β14. The HMBC correlations (Figure 1c) from δH 2.23 (4-Me) to δC 132.2 (d, C-3), δC 122.8 (s, C-4) and δC 156.1 (s, C-5), from δH 2.07 (8-Me) to δC 144.3 (s, C-7), δC 134.8 (s, C-8) and δC 128.4 (d, C-9) confirmed the presence of a phenyl ring in 2. As a result, the gross structure of 2 was established as shown in Figure 1. Biogenetically, the relative configuration of 2 was assigned as that of 1.

In conclusion, we obtained two new doramectin analogs from the culture broth of S. avermitilis NEAU1069. Along with previously obtained analogs of doramectin, avermectin and milbemycin from S. avermitilis NEAU1069,3, 4 we believe that these two new compounds possibly have important roles in understanding and perfecting the proposed biosynthetic pathways of avermectins and milbemycins.

Experimental procedure

General procedures and reagents

Melting points were measured using a Fisher-Johns micro-melting point apparatus (corrected; Fisher-Johns, Pittsburgh, PA, USA); UV spectra were obtained on a Varian CARY 300 BIO spectrophotometer (Varian, Palo Alto, CA, USA); IR spectra were recorded on a Nicolet Magna FT-IR 750 spectrometer (Nicolet Magna, Madison, WI, USA); 1H- and 13C-NMR spectra were measured using a Bruker DRX-400 (400 MHz for 1H and 100 MHz for 13C) spectrometer (Bruker, Rheinstetten, Germany); chemical shifts are reported in p.p.m. (δ) using the residual CHCl3 (δH 7.26; δC 77.0) as an internal standard, and coupling constant (J) in Hz. 1H and 13C-NMR assignments were supported by 1H-1H COSY, HMQC and HMBC experiments. The ESI-MS and HRESI-MS spectra were taken on a Q-TOF Micro LC-MS-MS mass spectrometer (Waters, Milford, MA, USA). Optical rotation was measured on a Perkin-Elmer 341 Polarimeter (Perkin-Elmer, Fremont, CA, USA). Column chromatography was carried out on silica gel (100–200 mesh, Qing Dao Hai Yang Chemical Group, Qingdao, China). Semi-preparative HPLC (Agilent 1100, Zorbax SB-C18, 5 μm, 250 × 9.4 mm i.d.; Agilent, Palo Alto, CA, USA) was further performed to obtain pure compounds. All chemicals used in the study, such as methanol (MeOH), ethyl acetate (EtOAc), petroleum ether (60–90 °C) and acetone, were of analytical grade.

Strain fermentation, isolation and purification of compounds

Details of the producing strain, S. avermitilis NEAU1069, were described in a previous paper.3, 4 The strain was maintained on a YMS medium containing soluble starch (Bei Jing Ao Bo Xing, Beijing, China) 10 g, yeast extract (Bei Jing Ao Bo Xing) 2 g, KNO3 1 g and agar 20 g in 1.0 l tap water, pH 7.0. The seed medium consisted of glucose (Bei Jing Ao Bo Xing) 20 g, soybean flour (Cormwin, Beijing, China) 15 g and yeast autolysate (Bei Jing Ao Bo Xing) 5.0 g in 1.0 l tap water, pH 7.0. Both the media were sterilized at 121 °C for 20 min. Slant cultures were incubated for 6–8 days at 28 °C. A total of 10 ml of sterile water was added to the slant of the YMS medium. The spores were scraped and transferred onto a sterile tube containing glass beads; the spore suspension was then filtered through six layers of a sterile filter cheesecloth and adjusted to 107–108 c.f.u. ml−1. A 2.0 ml of the spore suspension was inoculated into a 250-ml flask containing 25 ml of seed medium and incubated at 28 °C for 24 h, shaken at 250 r.p.m. Then, 8.0 ml of the culture was transferred into 1–l Erlenmeyer flask containing 100 ml of the producing medium consisting of corn starch (Cormwin) 10%, soybean powder (Bei Jing Ao Bo Xing) 1%, cotton flour (Cormwin) 1%, α-amylase (Bei Jing Ao Bo Xing) 0.02%, NaCl 0.1%, K2HPO4 0.2%, MgSO4 7H2O 0.1%, CaCO3 0.7%, cyclohexanecarboxylic acid 0.1%, pH 7.0, before sterilization. Fermentation was carried out at 28 °C for 12–13 days on a rotary shaker at 250 r.p.m.

The fermentation broth (30 l) was filtered. The resulting cake was washed with water, and both filtrate and wash were discarded. Methanol (10 l) was used to extract the washed cake. The MeOH extract was evaporated under reduced pressure to approximately 2 l at 45 °C and the resulting concentrate was extracted three times using an equal volume of EtOAc. The combined EtOAc phase was concentrated under reduced pressure to yield 25 g of oily substances. The residual oily substance was chromatographed on silica gel and eluted with a petroleum ether–acetone mixture (95:5–50:50, v/v). The fractions eluted with the petroleum ether–acetone mixture (95:5–75:25, v/v) were combined and evaporated to obtain a crude mixture. The crude mixture was applied to a silica gel column and eluted with a petroleum ether–EtOAc mixture (95:5–50:50, v/v) to give five fractions (A1–A5). Fraction A3 eluted with a mixture of petroleum ether–EtOAc (75:25, v/v) was also subjected to silica gel eluting with a petroleum ether–EtOAc mixture (85:5–75:25, v/v) to give two subfractions B1 and B2.

Semipreparative HPLC (Agilent 1100, Zorbax SB-C18, 5 μm, 250 × 9.4 mm i.d.) was used to obtain pure compounds. The eluate was monitored using a photodiode array detected at 220 nm, and the flow rate was 1.5 ml min−1 at room temperature. Subfraction B1 eluted with a mixture of petroleum ether–EtOAc (75:25, v/v) was further separated by semipreparative HPLC using a solvent containing a CH3OH–H2O mixture (92:8, v/v) to obtain compound 1 (tR 24.2 min, 40 mg) and compound 2 (tR 21.5 min, 11 mg).

Physicochemical properties of 1 and 2

Compound 1 (Figure 1a) C44H68O11, white amorphous powder; melting point 153–155 °C; [α]D25+51 (c 0.2, EtOH); UV (EtOH) λmax nm (log ɛ): 200 (4.57), 250 (4.18); IR (KBr), νmax cm−1: 3454, 2929, 2855, 1714, 1637, 1452, 1380, 1341, 1167, 1099, 990; 1H NMR (400 MHz, CDCl3) and 13C NMR (100 MHz, CDCl3) data see Table 1; ESI-MS m/z 795 [M+Na]+; HRESI-MS m/z 795.4649 [M+Na]+, calculated for C44H68O11Na 795.4654.

Compound 2 (Figure 1a) C43H62O10, white amorphous powder; melting point 146–148 °C; [α]D25+124 (c 0.09, EtOH); UV (EtOH) λmax nm (log ɛ): 200 (4.81), 245 (4.41); IR (KBr), νmax cm−1: 3451, 2928, 2856, 1701, 1614, 1503, 1451, 1378, 1279, 1162, 997; 1H NMR (400 MHz, CDCl3) and 13C NMR (100 MHz, CDCl3) data see Table 1; ESI-MS m/z 761 [M+Na]+; HRESI-MS m/z 761.4225 [M+Na]+, calculated for C43H62O10Na 761.4235.

Acid hydrolysis of 1. Compound 1 (5.0 mg) was dissolved in 1 M HCl (1 ml) and then heated at 80 °C for 4 h. Aglycone was extracted with CHCl3 three times, and the aqueous residue was evaporated under reduced pressure. The residue and the sugar obtained from selamectin, by the above procedure, were analyzed by TLC using chloroform–methanol (9:1, v/v) as a developing solvent. The spots were detected by spraying with anisaldehyde–H2SO4 reagent followed by heating, and the result showed that the two sugars have the identical RF values (RF=0.6).